A description needs its clinical context
HPPD involves recurring or persistent perceptual disturbances after substance exposure, with clinically significant distress or impairment and consideration of other causes. It is different from simply being acutely intoxicated. Honest discussion of timing, substances, prescribed medicines and symptoms helps assessment. [1]
A 2022 neuro-ophthalmology case series reported visual snow, floaters, afterimages and light sensitivity among its cases. Its small, selected sample cannot establish how common those symptoms are in everyone with HPPD. [2]
Context matters
Timing and exposure history help distinguish causes.
No single look
The same person may describe several phenomena.
No judgement
Care starts with a clear, honest conversation.
Terms in this guide
- Perceptual symptom
- A change in how sensory information is experienced.
- Case series
- Descriptions of a selected group, without a randomized comparison.
One condition. Different experiences.
Three original illustrations isolate different reported features. They are not separate diagnoses or formal HPPD subtypes.
Original VisualSim schematic illustrations, informed by the cited clinical descriptions. These are not study figures, patient recordings or validated severity levels. Clinical basis: source 1. Artwork: © VisualSim; see image provenance.
Overlapping symptoms, unsettled mechanisms
HPPD and visual snow can share perceptual symptoms. The 2022 series found that routine visual tests were often unremarkable in its cases, but that finding should not be used to assume every new symptom is harmless or that examinations are unnecessary. [2]
The literature proposes several mechanisms, but no single explanation accounts for every presentation. The often-used “type I/type II” distinction is a proposed literature framework, not a pair of formal DSM-5 diagnostic subtypes. [1]
What can look similar?
Visual snow syndrome
Persistent static may look similar. Substance history and the complete clinical pattern matter. [2]
Acute intoxication
Persistent symptoms after acute effects resolve require a different assessment from current intoxication. [1]
Other eye or neurological causes
Do not attribute a new blind area, one-eye loss or sudden neurological symptoms to an old HPPD label. [1]
Similar-looking symptoms can have different causes. A matching picture cannot establish a diagnosis.
What an assessment may involve
An assessment may include a detailed symptom and medication/substance history, eye examination and investigations selected for the presentation. Describe continuous versus episodic symptoms and their effect on sleep, reading, work and emotional wellbeing. [1]
- Build a timelineInclude exposures and medicines without assuming every symptom has the same cause.
- Describe separatelyStatic, trails, distortion and glare can be explained individually.
- Discuss supportAsk about treatment uncertainty, mental-health support and practical adjustments.
What may help—and what is still being studied
Treatment evidence remains limited. Published reports include several medicines and non-drug approaches, but the 2022 review emphasizes the need for controlled trials. A case improving after a treatment does not prove that treatment will work for another person. [2]
Do not start, stop or change prescribed medication based on a simulator or anecdote. Discuss ongoing substance exposure, distress and any treatment risks with a qualified clinician. [1]
A 2025 systematic review found 31 medication reports involving 87 people, mostly case reports or small series. Reported improvement is encouraging but cannot separate medication effects from natural change, selection or reporting bias. Controlled trials remain needed; the reported proportions are not a personal chance of recovery. [4]
What this can mean for daily life
Explain the visual impact
Use Reading or Moving object to show a symptom, then explain how daily activities are affected. The screen example does not quantify disability.
Keep the conversation broad
Describe anxiety, sleep and practical difficulties as well as the visual symptoms. Support needs are personal and deserve attention.
Bring a clearer description to your appointment
Choose the questions you want to discuss. These choices stay in this page’s memory.
Research, with the context left in
The published evidence is dominated by case reports, small series and reviews. Read treatment claims with their study design and missing information in view.
What the evidence supports
HPPD is recognized clinically, but its treatment evidence is still dominated by small observational reports. A recent large electronic-record study expands the association literature while introducing major coding and selection limitations. Bigger datasets do not resolve whether a treatment works or how common HPPD is among all people who have used psychedelics.
How we select and interpret researchNeven and Blom: Pharmacological Treatment of Hallucinogen Persisting Perception Disorder—a systematic review
The review identifies candidate treatments and important gaps, and explicitly states that it could not rank medicines by efficacy or establish an evidence-based treatment protocol.
Limits and applicability: Small heterogeneous samples, publication bias, comorbidity treatment and an uncertain natural history prevent causal interpretation of reported recovery percentages. Off-label case reports are not a self-treatment guide.
How to read this evidence: The strongest recent synthesis found for medications, but confidence in efficacy remains very limited because none of the included studies supplied a randomized placebo comparison.
Ford and colleagues: Hallucinogenic Persisting Perception Disorder—a case series and literature review
Visual snow, afterimages, floaters, light sensitivity and night-vision complaints overlapped with VSS. Clinical history and prior substance exposure were important to the assessment.
Limits and applicability: Referral selection, retrospective information and incomplete follow-up limit generalization. Mostly normal tests neither prove HPPD nor remove the need to investigate atypical symptoms.
How to read this evidence: Useful for describing possible visual presentations; very limited for estimating frequency, prognosis or treatment benefit.
Characterising the clinical associations of HPPD: a retrospective cohort study
HPPD-related records were associated with a complex mix of psychiatric, headache and somatic diagnoses, supporting the importance of comprehensive care.
Limits and applicability: Codes were not individually adjudicated; drug dose, context and polysubstance exposure were unavailable. Recording order may differ from true onset. Results do not establish causation, a population prevalence or that anxiety explains the visual symptoms.
How to read this evidence: A large exploratory association study, with substantial uncertainty about diagnostic specificity and generalizability because the authors report broad, nonspecific codes and a selected health-care population.
McConnell and colleagues: The neverending trip—HPPD and non-visual perceptual disturbances
Photosensitivity, sound sensitivity and a greater number of perceptual complaints were associated with the HPPD group.
Limits and applicability: The survey cannot establish which features preceded HPPD or predict who will develop it. Associations do not prove a common mechanism or provide a validated risk calculator.
How to read this evidence: Useful hypothesis-generating work about symptom overlap, with limited confidence in causal or predictive interpretations from a self-selected survey.
Questions researchers still need to answer
- How often does clinically adjudicated HPPD occur after different exposures, and what is its untreated course?
- Which treatments improve visual symptoms and functioning in randomized controlled studies, with harms and dependence risks measured?
- How can researchers distinguish persistent perceptual symptoms from brief non-distressing re-experiences, migraine aura, VSS, medication effects and other neurologic causes?
- Can future cohorts collect reliable timing, dose, substance composition and polysubstance exposure without stigmatizing participants?
These are editorial interpretations, not formal GRADE ratings or independent clinical review. A large sample, recent date or well-known publisher does not make every claim certain.
Trusted places to go next
Selected clinical references, research and support organizations. Each link explains who it is for.
HPPD clinical case series
Methods, individual cases and limitations of treatment evidence.
HPPD literature review
A deeper clinical overview, with the limitations of its evidence base.
EyeWiki: HPPD
Professional overview for discussion with a clinician.
2025 systematic treatment review
An updated evidence review; treatment claims need their study limitations.
Organizations & ways to connect
Selected charities, professional organizations and communities, with their scope and region. Official pages checked 24 October 2026. Community discussions are peer support; each external service has its own privacy and moderation rules.
Perception Restoration Foundation
Dedicated HPPD research funding, information and a specialist directory. Volunteer capacity is limited and the organization says replies may be slow; it cannot guarantee help with an individual case. Check clinician credentials and the primary evidence behind treatment claims.
Connections listed by the organization.
Fireside Project
Trained peer support for difficult experiences during or after psychedelic use. It is broader than HPPD and explicitly does not provide clinical or medical care. It is not an emergency service; review current availability and privacy terms on the host site.
Connections listed by the organization.
Macquarie University: HPPD research
Institutional record of research into HPPD and overlapping perceptual symptoms. This is a way to read research and identify the research team, not a treatment clinic or confirmation that a trial is recruiting.
North American Neuro-Ophthalmology Society
Professional directory that can help identify a neuro-ophthalmologist to assess persistent visual symptoms and other possible explanations. Not every listed clinician treats HPPD; check experience, referral requirements and coverage. This is care navigation, not an HPPD support charity.
Questions you may still have
Can an image distinguish HPPD from visual snow?
No. Similar visual phenomena can occur in both; the clinical history and assessment are essential. [2]
Are type I and type II formal DSM-5 subtypes?
No. These terms describe a proposed distinction used in parts of the literature. [1]
Does a normal eye test prove HPPD?
No. A normal result does not establish a diagnosis, and different symptoms can call for different investigations.
Sources, image credits and review status
Compiled by VisualSim from clinical references and published research. Sources checked 24 October 2026. Independent clinical review has not been recorded; no named clinical reviewer or clinical validation is claimed. Research evidence and its limitations are linked below.
- Martinotti et al. Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives (2018). Clinical information; sources checked 24 October 2026.
- Ford et al. Hallucinogenic Persisting Perception Disorder: A Case Series and Review of the Literature (2022). Clinical information; sources checked 24 October 2026.
- American Academy of Ophthalmology EyeWiki. HPPD. Clinical information; sources checked 24 October 2026.
- Neven and Blom. Pharmacological Treatment of Hallucinogen Persisting Perception Disorder: A Systematic Review (2025). Clinical information; sources checked 24 October 2026.
- Characterising the clinical associations of HPPD: a retrospective cohort study (2026). TriNetX electronic-health-record cohort with 25,778 people assigned HPPD-related diagnostic codes and comparison groups
- McConnell and colleagues: The neverending trip—HPPD and non-visual perceptual disturbances (2025). Cross-sectional survey of 138 people reporting HPPD and 116 controls
The simulator helps people communicate an experience. It cannot diagnose a condition, measure a visual field, or establish that someone is safe to drive.